Rubicon Partners with Diagenode for ChIP Sample Preparation
Monday, November 05, 2012
Combining Rubicon ThruPLEX™ and Diagenode technologies enables scientists to efficiently conduct high quality ChIP studies from small samples for NGS and array analysis.
Life Technologies Announces Third Quarter 2012 Results
Monday, November 05, 2012
Revenue for the third quarter was $911 million, a decrease of 1.9 percent over the $929 million reported for the third quarter of 2011. Excluding the impact of currency, revenue growth for the quarter was 1.4 percent compared to the same period of the prior year.
‘1000 Genomes Barrier' Broken
Thursday, November 01, 2012
A landmark project that has sequenced 1,092 human genomes from individuals around the world will help researchers to interpret the genetic changes in people with disease.
Good Start Genetics® Announces The Expansion of its NGS-Based Carrier Screening Service
Friday, October 26, 2012
The announcement means that Good Start Genetics' screening service, GoodStart Select™, now offers state-of-the-art testing for all 23 of the diseases recommended in guidelines set by the major medical societies.
Population Genetics Launches Populus Award 2012
Tuesday, October 16, 2012
Award offers financial and expert practical support for the completion of a multi-sample gene sequencing project using Population Genetics’ proprietary technologies.
Population Genetics Launches Funding Award for Novel Population Sequencing Studies
Monday, October 15, 2012
The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project.
ATLAS Biolabs Participates in Two European Research Projects
Thursday, October 11, 2012
Company to investigate DNA repair and cellular aging.
VelaDx Signs Agreement with Life Technologies to Develop IVD Tests on Ion PGM Sequencer
Wednesday, October 10, 2012
Semiconductor sequencing brings unprecedented power to diagnostic tests to transform personalized medicine.
Life Technologies Acquires Compendia Bioscience
Tuesday, October 09, 2012
Bioinformatics expertise will enable deeper engagement with established customer base of leading pharmaceutical companies.
|
|
|
|
|
|
